NCT02011282

Brief Summary

We will examine whether the application of electro-neuro-muscular stimulation (ENMS) in critical care patients, can decrease the impact or severity of the critical illness myopathy (CIM) or neuropathy. We will also assess whether electro-neuro-muscular stimulation affect the incidence density rate of nosocomial pneumonia in the ICU. Patients will be divided into two groups, Group A and Group B chosen at random. In Group A conventional physiotherapy will be applied while in Group B, ENMS will also be applied additional to physiotherapy, in the quadriceps muscles. The total time of applying ENMS will be 1 hour, it will be applied before the start of the physiotherapy per day of hospitalization and for 10 days in each patient. The definition of CIM will be based on pathology muscular biopsy (quadriceps). Patients will undergo biopsy on the 1st and 11th day after entering the study. The technique of Gomori Trichrome will be used to determine the existence or absence of myopathy. In addition the ATPase technique will be applied at different prices of PH (PH: 9,4, PH: 4,6 and PH : 4.3), thus achieving a separation of myopathy and neuropathy. The primary outcome of the study will be the incidence of myopathy in both groups, at day 12th. Considering that the incidence of myopathy in critically ill patients is 80% reducing this rate by 50% in the intervention group using statistical power equal to 0.80 up to a level of p \<0.05, 12 number of patients will be required in each group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 9, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 13, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

March 30, 2015

Status Verified

August 1, 2014

Enrollment Period

1.4 years

First QC Date

December 9, 2013

Last Update Submit

March 27, 2015

Conditions

Keywords

ICU,MYOPATHY,NEUROPATHY,PNEUMONIA

Outcome Measures

Primary Outcomes (1)

  • incidence of myopathy

    Presence of myopathy in critical care patients; myopathy will be assessed with biopsy of quadriceps at day 12 after entering the study (17 day of ICU hospitalization)

    12 days

Secondary Outcomes (1)

  • NEUROPATHY

    12 days

Other Outcomes (1)

  • ventilator associated pneumonia

    28 days

Study Arms (2)

Electro-Neuro-Muscular Stimulation

EXPERIMENTAL

Patients will receive daily sessions of electrostimulation with a commercially available device (En-Stimulation 4, Netherlands) in the quadriceps muscle for 10 days

Other: Patients will receive daily sessions of electro-neuro-stimulation in the quadriceps muscle for 10 days

Control

NO INTERVENTION

Patients in this arm will receive the usual standard treatment

Interventions

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged\>18 years old and \<85 years old, hospitalized in the ICU for at least 96 hours

You may not qualify if:

  • pregnancy, autoimmune disease, pre-existing known neuromuscular diseases, presence of bone fractures on the lower extremities, use of corticoids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Icu University Hospital Larissa

Larissa, Thessaly, 41110, Greece

Location

MeSH Terms

Conditions

Muscular DiseasesPneumonia

Condition Hierarchy (Ancestors)

Musculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesRespiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • EPAMINONDAS ZAKYNTHINOS, PROF

    University of Thessaly

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
ASS. Professor in Critical Care Medicine

Study Record Dates

First Submitted

December 9, 2013

First Posted

December 13, 2013

Study Start

October 1, 2013

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

March 30, 2015

Record last verified: 2014-08

Locations